Dr. Linden Doss, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $882.40 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $255.19 | 4 | $0 (2024) |
| Amgen Inc. | $154.91 | 5 | $0 (2024) |
| Sight Sciences, Inc. | $124.68 | 1 | $0 (2023) |
| Horizon Therapeutics plc | $112.54 | 6 | $0 (2022) |
| Dompe US, Inc. | $111.04 | 1 | $0 (2024) |
| Allergan, Inc. | $104.85 | 1 | $0 (2020) |
| Tarsus Pharmaceuticals, Inc. | $19.19 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $389.31 | 8 | Amgen Inc. ($154.91) |
| 2023 | $143.08 | 2 | Sight Sciences, Inc. ($124.68) |
| 2022 | $166.07 | 4 | Bausch & Lomb Americas Inc. ($132.62) |
| 2021 | $79.09 | 4 | Horizon Therapeutics plc ($79.09) |
| 2020 | $104.85 | 1 | Allergan, Inc. ($104.85) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $109.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/02/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/13/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $104.17 | General |
| Category: Ophthalmology | ||||||
| 02/22/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $111.04 | General |
| Category: SOLUTION/ DROPS | ||||||
| 08/29/2023 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $18.40 | General |
| 01/18/2023 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $124.68 | General |
| Category: Ophthalmology | ||||||
| 11/30/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: TEPEZZA | ||||||
| 09/08/2022 | Bausch & Lomb Americas Inc. | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $111.05 | General |
| Category: Ophthalmology | ||||||
| 06/02/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: TEPEZZA | ||||||
| 02/16/2022 | Bausch & Lomb Americas Inc. | PROLENSA (Drug), LOTEMAX SM, VYZULTA | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Ophthalmology | ||||||
| 12/08/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: TEPEZZA | ||||||
| 09/17/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $44.04 | General |
| Category: TEPEZZA | ||||||
| 09/01/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: TEPEZZA | ||||||
| 08/18/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: TEPEZZA | ||||||
| 01/27/2020 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $104.85 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 166 | 170 | $61,290 | $25,877 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 23 | 23 | $37,195 | $16,447 | 44.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 56 | 58 | $16,646 | $6,593 | 39.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 16 | 16 | $2,276 | $910.13 | 40.0% |
| 92285 | Photography of content of eyes | Office | 2023 | 39 | 41 | $2,214 | $792.76 | 35.8% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 17 | 17 | $1,819 | $723.35 | 39.8% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 15 | 15 | $1,140 | $409.93 | 36.0% |
About Dr. Linden Doss, M.D
Dr. Linden Doss, M.D is a Ophthalmic Plastic and Reconstructive Surgery healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1376990424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Linden Doss, M.D has received a total of $882.40 in payments from pharmaceutical and medical device companies, with $389.31 received in 2024. These payments were reported across 19 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($882.40).
As a Medicare-enrolled provider, Doss has provided services to 166 Medicare beneficiaries, totaling 170 services with total Medicare billing of $25,877. Data is available for 1 year (2023–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Ophthalmic Plastic and Reconstructive Surgery
- Other Specialties Student in an Organized Health Care Education/Training Program, Ophthalmology
- Location Los Angeles, CA
- Active Since 05/18/2016
- Last Updated 12/17/2025
- Taxonomy Code 207WX0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376990424
Products in Payments
- TEPEZZA (Biological) $154.91
- OMNI SURGICAL SYSTEM (Device) $124.68
- TEPEZZA (Drug) $112.54
- LOTEMAX SM (Drug) $111.05
- OXERVATE (Drug) $111.04
- MIEBO (Drug) $104.17
- PROLENSA (Drug) $21.57
- XDEMVY (Drug) $19.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmic Plastic and Reconstructive Surgery Doctors in Los Angeles
Dr. Soheab Ugradar, Md, MD
Ophthalmic Plastic and Reconstructive Surgery — Payments: $122,139
Robert Goldberg, Md, MD
Ophthalmic Plastic and Reconstructive Surgery — Payments: $4,018
Kelsey Roelofs, Md, MD
Ophthalmic Plastic and Reconstructive Surgery — Payments: $2,163
Christopher Lo, M.d, M.D
Ophthalmic Plastic and Reconstructive Surgery — Payments: $1,660
Frank Mei, Md, MD
Ophthalmic Plastic and Reconstructive Surgery — Payments: $1,498
Farzad Pakdel
Ophthalmic Plastic and Reconstructive Surgery